Comparison of Obturator Nerve Blockade and Neuromuscular Blockade
Completed · Phase 4
Conditions studied: Cancer of Bladder
In brief
Patients diagnosed with posterolateral bladder tumors will be invited to participate in the study. Subjects will be randomized to receive an ultrasound-guided obturator block or a neuromuscular blocking agent after the induction of general anesthesia in an attempt to block the obturator reflex during surgery.
Key facts
- Study ID
- NCT03063255
- Run by
- University of Florida
- People needed
- 60
- Starts
- 2017-04-25
- Expected to finish
- 2019-09-19
- Last updated by the study team
- 2021-03-24
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients ≥ 18 years of age
- Planned TURBT for unilateral or bilateral posterolateral bladder tumors
- Ability to understand and provide informed consent
You may not qualify if…
- Patient refusal or inability to provide informed consent
- True allergy, not sensitivity, to local anesthetics
- True allergy, not sensitivity, Propofol
- True allergy, not sensitivity, general anesthetic agents
- Pregnancy
- Severe hepatic impairment
- Evidence of infection at or near the proposed needle insertion site
- Any sensorimotor deficit of the lower extremity, whether acute or chronic
- Inability to walk without assistance
- Lower extremity joint replacement surgery in the preceding six months
Where it is running
- Malcom Randall VA Medical Center — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.